TTRX
Turn Therapeutics Inc.
1W: -0.9%
1M: -2.3%
3M: +13.3%
YTD: -27.5%
$3.40
-0.01 (-0.29%)
After Hours: $3.32 (-0.08, -2.35%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$100.1M
52W Range2.57-26.5
Volume36,105
Avg Volume36,681
Beta6.42
Dividend—
Analyst Ratings
Company Info
CEOBradley E. Burnam
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2025-10-08
Websiteturntherapeutics.com
250 N Westlake Blvd
Westlake Village, CA 91362
US
Westlake Village, CA 91362
US
818 546 4011
About Turn Therapeutics Inc.
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Latest News
Turn Therapeutics secures up to $25M in financing from Avenue Capital Group
Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Recent Insider Trades
No insider trades found